These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6171883)

  • 1. Substance P counteracts neurotoxin damage on norepinephrine neurons in rat brain during ontogeny.
    Jonsson G; Hallman H
    Science; 1982 Jan; 215(4528):75-7. PubMed ID: 6171883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance P modifies the 6-hydroxydopamine induced alteration of postnatal development of central noradrenaline neurons.
    Jonsson G; Hallman H
    Neuroscience; 1982; 7(11):2909-18. PubMed ID: 6185880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of substance P on the 5,7-dihydroxytryptamine induced alteration of the postnatal development of central serotonin neurons.
    Jonsson G; Hallman H
    Med Biol; 1983 Apr; 61(2):105-12. PubMed ID: 6192293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of 6-hydroxydopamine induced alteration of the postnatal development of central noradrenaline neurons.
    Jonsson G; Hallman H
    Brain Res Bull; 1982; 9(1-6):635-40. PubMed ID: 6184133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of substance P on neonatally axotomized noradrenaline neurons in rat brain.
    Jonsson G; Hallman H
    Med Biol; 1983 Jun; 61(3):179-85. PubMed ID: 6195493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of central monoamine neurons following an early neurotoxic lesion.
    Jonsson G; Hallman H
    Bibl Anat; 1982; (23):76-92. PubMed ID: 6291505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GM1 ganglioside enhances regrowth of noradrenaline nerve terminals in rat cerebral cortex lesioned by the neurotoxin 6-hydroxydopamine.
    Kojima H; Gorio A; Janigro D; Jonsson G
    Neuroscience; 1984 Dec; 13(4):1011-22. PubMed ID: 6441897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of neonatal nicotine administration on the postnatal development of central noradrenaline neurons.
    Jonsson G; Hallman H
    Acta Physiol Scand Suppl; 1980; 479():25-6. PubMed ID: 6932801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta-Endorphin-induced stimulation of central sympathetic outflow: inhibitory modulation by central noradrenergic neurons.
    Appel NM; Van Loon GR
    J Pharmacol Exp Ther; 1986 Jun; 237(3):695-701. PubMed ID: 2940358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The structure of cerebral cortex in the rat following prenatal administration of 6-hydroxydopamine.
    Lidov HG; Molliver ME
    Brain Res; 1982 Jan; 255(1):81-108. PubMed ID: 6799150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The actions of xylamine on central noradrenergic neurons.
    Dudley MW; Butcher LL; Kammerer RC; Cho AK
    J Pharmacol Exp Ther; 1981 Jun; 217(3):834-40. PubMed ID: 7230010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of morphine on the 6-hydroxydopamine induced changes of the postnatal development of central noradrenaline neurons.
    Jonsson G; Hallman H
    Med Biol; 1982 Aug; 60(4):191-8. PubMed ID: 6128445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 6-hydroxydopamine on central noradrenaline neurons during ontogeny.
    Sachs C; Jonsson G
    Brain Res; 1975 Dec; 99(2):277-91. PubMed ID: 1182547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of 6-hydroxydopamine neurotoxicity.
    Cohen G; Allis B; Winston B; Mytilineou C; Heikkila R
    Eur J Pharmacol; 1975 Aug; 33(1):217-21. PubMed ID: 1175689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noradrenaline and dopamine interaction in rat brain during development.
    Ponzio F; Hallman H; Jonsson G
    Med Biol; 1981 Jun; 59(3):161-9. PubMed ID: 6796787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracisternal dose-response analysis of 6-hydroxydopamine-induced noradrenergic sprouting in the neonatal rat cerebellum.
    Schmidt RH; Bhatnagar RK
    J Pharmacol Exp Ther; 1980 Mar; 212(3):456-61. PubMed ID: 7359347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered development of central noradrenaline neurons during ontogeny by 6-hydroxydopamine.
    Sachs C; Pycock C; Jonsson G
    Med Biol; 1974 Feb; 52(1):55-65. PubMed ID: 4220378
    [No Abstract]   [Full Text] [Related]  

  • 18. Developmental plasticity of central noradrenaline neurons after neonatal damage--changes in transmitter functions.
    Jonsson G; Wiesel FA; Hallman H
    J Neurobiol; 1979 Jul; 10(4):337-53. PubMed ID: 224143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effect of various 6-hydroxydopa treatments on the development of central and peripheral noradrenergic neurons.
    Jaim-Etcheverry G; Zieher LM
    Eur J Pharmacol; 1977 Sep; 45(2):105-16. PubMed ID: 902684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional development of norepinephrine, dopamine-beta-hydroxylase and tyrosine hydroxylase in the rat brain subsequent to neonatal treatment with subcutaneous 6-hydroxydopamine.
    Schmidt RH; Bhatnagar RK
    Brain Res; 1979 Apr; 166(2):293-308. PubMed ID: 34468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.